AU2002216087A1 - Novel substituted imidazotriazinones as pde ii-inhibitors - Google Patents
Novel substituted imidazotriazinones as pde ii-inhibitorsInfo
- Publication number
- AU2002216087A1 AU2002216087A1 AU2002216087A AU1608702A AU2002216087A1 AU 2002216087 A1 AU2002216087 A1 AU 2002216087A1 AU 2002216087 A AU2002216087 A AU 2002216087A AU 1608702 A AU1608702 A AU 1608702A AU 2002216087 A1 AU2002216087 A1 AU 2002216087A1
- Authority
- AU
- Australia
- Prior art keywords
- pde
- inhibitors
- novel substituted
- substituted imidazotriazinones
- imidazotriazinones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10064105 | 2000-12-21 | ||
DE10064105A DE10064105A1 (en) | 2000-12-21 | 2000-12-21 | New substituted imidazotriazinones |
PCT/EP2001/014450 WO2002050078A1 (en) | 2000-12-21 | 2001-12-10 | Novel substituted imidazotriazinones as pde ii-inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002216087A1 true AU2002216087A1 (en) | 2002-07-01 |
Family
ID=7668333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216087A Abandoned AU2002216087A1 (en) | 2000-12-21 | 2001-12-10 | Novel substituted imidazotriazinones as pde ii-inhibitors |
Country Status (15)
Country | Link |
---|---|
US (1) | US6573263B2 (en) |
EP (1) | EP1347978B1 (en) |
JP (1) | JP2004525098A (en) |
AR (1) | AR034423A1 (en) |
AU (1) | AU2002216087A1 (en) |
CA (1) | CA2431965A1 (en) |
DE (2) | DE10064105A1 (en) |
DO (1) | DOP2001000297A (en) |
ES (1) | ES2248228T3 (en) |
GT (1) | GT200100254A (en) |
HN (1) | HN2001000281A (en) |
PE (1) | PE20020756A1 (en) |
SV (1) | SV2002000776A (en) |
UY (1) | UY27080A1 (en) |
WO (1) | WO2002050078A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7087605B2 (en) | 2001-06-01 | 2006-08-08 | Bayer Aktiengesellschaft | 5-Ethyl-imidazotriazinones |
GB0113342D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 1 |
CA2473181A1 (en) * | 2002-02-04 | 2003-08-14 | F. Hoffmann-La Roche Ag | Quinoline derivatives as npy antagonists |
MXPA05000131A (en) * | 2002-07-05 | 2005-04-11 | Hoffmann La Roche | Quinazoline derivatives. |
EP1539722A1 (en) * | 2002-08-07 | 2005-06-15 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
JP2006219374A (en) | 2003-06-13 | 2006-08-24 | Daiichi Asubio Pharma Co Ltd | Imidazotriazinone derivative having pde 7 inhibition |
PE20142258A1 (en) | 2012-04-25 | 2015-01-15 | Takeda Pharmaceutical | NITROGENATED HETEROCYCLIC COMPOUND |
US9527841B2 (en) | 2012-07-13 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors |
EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
US10053468B2 (en) | 2013-07-03 | 2018-08-21 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2015002230A1 (en) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | Amide compound |
US9815796B2 (en) | 2013-12-23 | 2017-11-14 | Merck Sharp & Dohme Corp. | Pyrimidone carboxamide compounds as PDE2 inhibitors |
JP6696904B2 (en) * | 2014-01-08 | 2020-05-20 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | Formulations and pharmaceutical compositions |
PT3597649T (en) | 2014-04-23 | 2022-01-21 | Dart Neuroscience Llc | Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors |
TWI568737B (en) | 2014-11-05 | 2017-02-01 | 達特神經科學(開曼)有限責任公司 | Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as pde2 inhibitors |
JP6608934B2 (en) | 2014-12-06 | 2019-11-20 | イントラ−セルラー・セラピーズ・インコーポレイテッド | Organic compounds |
JP6608933B2 (en) | 2014-12-06 | 2019-11-20 | イントラ−セルラー・セラピーズ・インコーポレイテッド | Organic compounds |
WO2016145614A1 (en) | 2015-03-17 | 2016-09-22 | Merck Sharp & Dohme Corp. | Triazolyl pyrimidinone compounds as pde2 inhibitors |
EP3285581B1 (en) | 2015-03-26 | 2021-08-11 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as pde2 inhibitors |
US10195201B2 (en) | 2015-05-05 | 2019-02-05 | Merck Sharp & Dohme Corp. | Heteroaryl-pyrimidinone compounds as PDE2 inhibitors |
WO2016183741A1 (en) | 2015-05-15 | 2016-11-24 | Merck Sharp & Dohme Corp. | Pyrimidinone amide compounds as pde2 inhibitors |
WO2016191935A1 (en) | 2015-05-29 | 2016-12-08 | Merck Sharp & Dohme Corp. | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016192083A1 (en) | 2015-06-04 | 2016-12-08 | Merck Sharp & Dohme Corp. | Dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016209749A1 (en) | 2015-06-25 | 2016-12-29 | Merck Sharp & Dohme Corp. | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors |
WO2017000276A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
JP2021504466A (en) | 2017-11-23 | 2021-02-15 | オスロ ウニヴェルシティ ホスピタル ホーエフ | Treatment of tachycardia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK109578A (en) | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS |
DE19541264A1 (en) | 1995-11-06 | 1997-05-07 | Bayer Ag | Purin-6-one derivatives |
DE19709877A1 (en) | 1997-03-11 | 1998-09-17 | Bayer Ag | 1,5-dihydro-pyrazolo [3,4-d] pyrimidinone derivatives |
IL135462A0 (en) * | 1997-11-12 | 2001-05-20 | Bayer Ag | 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
DE19827640A1 (en) * | 1998-06-20 | 1999-12-23 | Bayer Ag | New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
DE19838705A1 (en) | 1998-08-26 | 2000-03-02 | Bayer Ag | New dihydro- (1,2,3) -triazolo- [4,5-d] pyrimidin-7-ones |
-
2000
- 2000-12-21 DE DE10064105A patent/DE10064105A1/en not_active Withdrawn
-
2001
- 2001-11-30 DO DO2001000297A patent/DOP2001000297A/en unknown
- 2001-12-07 AR ARP010105704A patent/AR034423A1/en unknown
- 2001-12-10 DE DE50107316T patent/DE50107316D1/en not_active Expired - Fee Related
- 2001-12-10 ES ES01271375T patent/ES2248228T3/en not_active Expired - Lifetime
- 2001-12-10 JP JP2002551971A patent/JP2004525098A/en active Pending
- 2001-12-10 WO PCT/EP2001/014450 patent/WO2002050078A1/en active IP Right Grant
- 2001-12-10 EP EP01271375A patent/EP1347978B1/en not_active Expired - Lifetime
- 2001-12-10 AU AU2002216087A patent/AU2002216087A1/en not_active Abandoned
- 2001-12-10 CA CA002431965A patent/CA2431965A1/en not_active Abandoned
- 2001-12-18 UY UY27080A patent/UY27080A1/en not_active Application Discontinuation
- 2001-12-19 GT GT200100254A patent/GT200100254A/en unknown
- 2001-12-19 HN HN2001000281A patent/HN2001000281A/en unknown
- 2001-12-20 PE PE2001001277A patent/PE20020756A1/en not_active Application Discontinuation
- 2001-12-20 SV SV2001000776A patent/SV2002000776A/en unknown
- 2001-12-21 US US10/026,310 patent/US6573263B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1347978B1 (en) | 2005-08-31 |
AR034423A1 (en) | 2004-02-25 |
DOP2001000297A (en) | 2003-08-15 |
PE20020756A1 (en) | 2002-10-02 |
UY27080A1 (en) | 2002-07-31 |
DE10064105A1 (en) | 2002-06-27 |
ES2248228T3 (en) | 2006-03-16 |
DE50107316D1 (en) | 2005-10-06 |
US6573263B2 (en) | 2003-06-03 |
EP1347978A1 (en) | 2003-10-01 |
US20020198377A1 (en) | 2002-12-26 |
JP2004525098A (en) | 2004-08-19 |
SV2002000776A (en) | 2002-12-02 |
WO2002050078A1 (en) | 2002-06-27 |
GT200100254A (en) | 2002-08-19 |
CA2431965A1 (en) | 2002-06-27 |
HN2001000281A (en) | 2003-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002216087A1 (en) | Novel substituted imidazotriazinones as pde ii-inhibitors | |
AU2002218266A1 (en) | Novel indanylidene compounds | |
AU2001252574A1 (en) | Novel bicyclic compounds | |
AU2001292518A1 (en) | Novel compounds | |
AU2001239765A1 (en) | Novel compounds | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU2001280167A1 (en) | Novel propenohydroxamic acid derivatives | |
AU2001246998A1 (en) | Novel compounds | |
AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
AU2001253362A1 (en) | Novel compounds | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2002231077A1 (en) | Novel compounds | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2001288110A1 (en) | Spiro compounds | |
AU2001256964A1 (en) | Novel compounds | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
AU2001252575A1 (en) | Novel tricyclic compounds | |
AU2002363600A1 (en) | Novel phenyl-propargylether derivatives | |
AU2001230689A1 (en) | Novel compounds | |
AU2002217285A1 (en) | Compounds | |
AU2002221923A1 (en) | Novel compounds | |
AU2002216060A1 (en) | Novel compounds | |
AU2001276890A1 (en) | Novel compounds |